Aldactone and Bextra drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Aldactone (spironolactone) and Bextra (valdecoxib). Common drug interactions include angina pectoris among females and acute myocardial infarction among males.

The phase IV clinical study analyzes what interactions people have when they take Aldactone and Bextra. It is created by eHealthMe based on reports of 58 people who take the same drugs from the FDA, and is updated regularly.

What is Aldactone?

Aldactone has active ingredients of spironolactone. It is often used in acne. eHealthMe is studying from 46,063 Aldactone users. Check the latest studies of Aldactone.

What is Bextra?

Bextra has active ingredients of valdecoxib. It is often used in pain. eHealthMe is studying from 20,994 Bextra users. Check the latest studies of Bextra.



On Jul, 16, 2026

58 people who take Aldactone and Bextra together, and have interactions are studied.

Aldactone and Bextra drug interactions.

What are the common drug interactions of Aldactone and Bextra, by gender? *:

female:

  1. Angina pectoris (chest pain due to ischemia of the heart muscle)
  2. Anxiety
  3. Back pain
  4. Blood cholesterol increased
  5. Blood creatinine decreased
  6. Breast cancer
  7. Cardiac failure congestive
  8. Cardiomegaly (increased size of heart than normal)
  9. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  10. Coronary artery stenosis (narrowing of coronary artery)

male:

  1. Acute myocardial infarction (acute heart attack)
  2. Cardiogenic shock (inadequate circulation of blood)
  3. Tooth extraction
  4. Abdominal distension
  5. Gastric ulcer (stomach ulcer)
  6. Gastritis (inflammation of stomach)
  7. Hepatitis (inflammation of the liver)
  8. Jaw disorder (jaw disease)
  9. Paralysis
  10. Renal disorder (kidney disease)

What are the common drug interactions of Aldactone and Bextra, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Anxiety
  2. Cough
  3. Insomnia (sleeplessness)
  4. Somnolence (a state of near-sleep, a strong desire for sleep)

30-39:

  1. Blood potassium increased
  2. Cardiac failure
  3. Decreased appetite
  4. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  5. Hypophagia (reduced food intake)
  6. Hypotension (abnormally low blood pressure)
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
  9. Urine output decreased

40-49:

  1. Insomnia (sleeplessness)
  2. Back pain
  3. Contusion (a type of hematoma of tissue in which capillaries)
  4. Dizziness
  5. Dyspnoea (difficult or laboured respiration)
  6. Fall
  7. Muscle strain (an injury to a muscle in which the muscle fibres tear)
  8. Muscular weakness (muscle weakness)
  9. Vomiting
  10. Angina pectoris (chest pain due to ischemia of the heart muscle)

50-59:

  1. Rash papular (redness with papule)
  2. Abdominal pain
  3. Burning sensation
  4. Chest pain
  5. Dermatitis allergic (inflammation of the skin due allergic reaction)
  6. Obesity (having too much body fat)
  7. Skin plaque (red, scaly patches to appear on the skin)
  8. Swelling face
  9. Blood cholesterol increased
  10. Breast cancer

60+:

  1. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  2. Hip fracture
  3. General physical health deterioration (weak health status)
  4. Post procedural infection
  5. Renal failure acute (rapid kidney dysfunction)
  6. Vomiting
  7. Acute myocardial infarction (acute heart attack)
  8. Asthenia (weakness)
  9. Blood pressure decreased
  10. Cardiogenic shock (inadequate circulation of blood)

What are the existing conditions these people have? *

  1. Depression: 19 people, 32.76%
  2. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 8.62%
  3. Stress And Anxiety: 4 people, 6.90%
  4. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 4 people, 6.90%
  5. High Blood Pressure: 3 people, 5.17%
  6. Hair Growth Abnormal: 3 people, 5.17%
  7. Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 3 people, 5.17%
  8. Bipolar Disorder (mood disorder): 3 people, 5.17%
  9. Back Pain: 3 people, 5.17%
  10. Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 5.17%

* Approximation only. Some reports may have incomplete information.

Do you take Aldactone and Bextra?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Aldactone and Bextra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Aldactone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Bextra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Aldactone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bextra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on spironolactone and valdecoxib (the active ingredients of Aldactone and Bextra, respectively), and Aldactone and Bextra (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: